A support ecosystem
A central collaboration platform for device makers, AI innovators, hospitals, researchers, and capital.
A GLOBAL ALLIANCE
We support the heroes building the future of congenital heart care.
If you are a non-profit, device maker, innovator, clinician, regulator, or investor — we are your Hero Support
1 in 100
Births affected by CHD
90%+
Now survive into adulthood
9+
Fragmented innovation sectors
0
Global commercialization bodies — until now
Our mission
Closing the gap between breakthroughs and the families who need it.
The Global Congenital Heart Alliance exists as a unifying support ecosystem — accelerating development, commercialization, and global adoption of the technologies that will transform lifelong congenital cardiovascular care.
Read the executive briefFour strategic objectives
What our industry alliance unlocks.
Accelerated commercialization
Regulatory guidance, market access, clinical partnerships, procurement and reimbursement navigation.
Advocate for the sector
Pediatric innovation incentives, trial modernization, harmonization and real-world evidence frameworks.
Set shared standards
Registries, interoperability, working groups, and clinical-commercial partnerships.
Flagship programs
The support platform you have been missing.
Focused Virtual Innovation Summits
Cardiologists, founders, AI companies, regulators and investors
Market Access Council
Health pathways, economics, and commercialization
Innovation Accelerator
KOL matchmaking, hospital pilots, commercialization mentorship and venture readiness for startups.
Congenital Innovation Registry
Shared outcomes data, real-world evidence, and AI-ready datasets for multi-center collaboration.
Founding coalition · 2026
Help shape the alliance to be the support you need.
We are recruiting founding members, advisory council partners, and anchor partners across industry, clinical leadership, and capital. The first cohort defines the standards.
